FASN and colorectal carcinoma: Even though numerous studies show the benefit of targeting FASN in cancer including CRC, knowledge about the contribution of lipid synthesis to CRC initiation is very limited, and the utility of this pathway as a therapeutic target for the early stages of this disease is unclear.